ARCN1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.545200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.579800E-01
Normal-vs-Stage2
2.623200E-01
Normal-vs-Stage3
9.559800E-01
Normal-vs-Stage4
6.746000E-02
Stage1-vs-Stage2
8.222800E-01
Stage1-vs-Stage3
4.037000E-01
Stage1-vs-Stage4
1.741600E-01
Stage2-vs-Stage3
2.294400E-01
Stage2-vs-Stage4
1.971630E-01
Stage3-vs-Stage4
9.244000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.641800E-01
Normal-vs-AfricanAmerican
7.561600E-02
Normal-vs-Asian
5.191600E-01
Caucasian-vs-AfricanAmerican
3.225000E-01
Caucasian-vs-Asian
8.552400E-01
AfricanAmerican-vs-Asian
4.722800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.885800E-01
Normal-vs-Female
2.267600E-01
Male-vs-Female
8.396800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.715400E-01
Normal-vs-Age(41-60Yrs)
5.954300E-02
Normal-vs-Age(61-80Yrs)
3.914400E-01
Normal-vs-Age(81-100Yrs)
3.784200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.309700E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.702600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.483200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.321000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.897800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.413200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.091200E-01
Normal-vs-Daily Drinker
6.141200E-01
Normal-vs-Weekly Drinker
3.417600E-01
Normal-vs-Occasional Drinker
1.919440E-01
Normal-vs-Social Drinker
1.528150E-01
Non Drinker-vs-Daily Drinker
7.579000E-01
Non Drinker-vs-Weekly Drinker
4.508000E-01
Non Drinker-vs-Occasional Drinker
1.610760E-01
Non Drinker-vs-Social Drinker
2.811200E-01
Daily Drinker-vs-Weekly Drinker
3.414600E-01
Daily Drinker-vs-Occasional Drinker
1.149770E-01
Daily Drinker-vs-Social Drinker
1.908210E-01
Weekly Drinker-vs-Occasional Drinker
6.426200E-01
Weekly Drinker-vs-Social Drinker
8.472000E-01
Occasional Drinker-vs-Social Drinker
7.379000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.293800E-01
Normal-vs-Grade 2
8.325400E-01
Normal-vs-Grade 3
7.941400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.358000E-02
Grade 1-vs-Grade 3
1.728410E-02
Grade 1-vs-Grade 4
9.293800E-01
Grade 2-vs-Grade 3
3.265000E-01
Grade 2-vs-Grade 4
8.325400E-01
Grade 3-vs-Grade 4
7.941400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.188400E-01
Normal-vs-NonDiabetic
2.511800E-01
Diabetic-vs-NonDiabetic
1.068830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.690000E-02
Normal-vs-NoPancreatitis
3.252400E-01
Pancreatitis-vs-NoPancreatitis
2.616000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.544620E-01
Normal-vs-N1
2.737800E-01
N0-vs-N1
4.422600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.783600E-02
Normal-vs-TP53-NonMutant
4.238400E-01
TP53-Mutant-vs-TP53-NonMutant
7.89260000000347E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
